Skip to content

Study on the relationship between drug dose and distribution of transdisc lumbar sympathetic block

Study on the relationship between drug dose and distribution of transdisc lumbar sympathetic block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063383
Enrollment
Unknown
Registered
2022-09-05
Start date
2022-09-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular neuropathies diseases of the lower limbs

Interventions

Group 1ml:1ml of the liquid solution was injected
Group 3ml:3ml of the liquid solution was injected
Group 5ml:5ml of the liquid solution was injected

Sponsors

The Fourth Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Severe clinical symptoms appear, which affect the daily work and life; 2. Drug treatment is ineffective for more than 6 weeks long; 3. Those who refuse to open, endoscopic lumbar sympathectomy, or are unable to tolerate general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Severe systemic or waist infection; 2. lumbar severe anatomical deformity or surgical history; 3. Allto contrast agent, local anesthetic and ethanol; 4. Women during pregnancy or lactation; 5. Severe heart, lung and renal insufficiency; 6. Unable to tolerate the prone position; 7. Refuse to join the experimenter.

Design outcomes

Primary

MeasureTime frame
Drug distribution;Lower limb temperature;

Countries

China

Contacts

Public ContactHuacheng Zhou

The Fourth Affiliated Hospital of Harbin Medical University

zhouhuacheng@163.com+86 13936184872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026